Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03546361
Brief Title: CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer

First Submitted : May 23, 2018
First Submitted that Met QC Criteria : May 23, 2018
First Posted : June 6, 2018

Last Update Submitted that Met QC Criteria : February 23, 2021
Last Update Posted : February 25, 2021